Ayala Pharmaceuticals (NASDAQ:ADXS) Research Coverage Started at StockNews.com
StockNews.com initiated coverage on shares of Ayala Pharmaceuticals (NASDAQ:ADXS – Get Rating) in a research note issued to investors on Thursday. The brokerage issued a sell rating on the stock. Ayala Pharmaceuticals Price Performance NASDAQ:ADXS opened at $0.95 on Thursday. Ayala Pharmaceuticals has a 52 week low of $0.65 and a 52 week high of […]